Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Non Controlled, Multicenter, First-in-Human Study for the Evaluation of the Safety, Pharmacokinetics and Preliminary Antitumor Activity of GM102 in Patients With Advanced Pretreated Gynecological Cancer

NCT02978755 is registered in ClinicalTrials.gov with GamaMabs Pharma as lead sponsor.

NCT NCT02978755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02978755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Non Controlled, Multicenter, First-in-Human Study for the Evaluation of the Safety, Pharmacokinetics and Preliminary Antitumor Activity of GM102 in Patients With Advanced Pretreated Gynecological Cancer
Lead sponsor
GamaMabs Pharma
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2016
Completion date
June 10, 2020
Enrollment
78 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm, gynecologic